Approval · Notice of Compliance 5403 · 2003
SINGULAIR: Notice of Compliance 5403
Issued August 27, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5403
- Date
- August 27, 2003
- Company
- Merck Frosst Canada & Cie, Merck Frosst Canada & Co.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form
- Therapeutic class
- Leukotriene receptor antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SINGULAIR | 02247997 | Cancelled Post Market |
Medicinal ingredients
- MONTELUKAST SODIUM 4 MG per PCK